Prof. Bo Jiang 江波
Chief Physician, Professor
Department of Colorectal and Anal Surgery, Shanxi Cancer Hospital, Taiyuan
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Radical and extended radical surgery for colorectal tumors, including colon and rectal cancer. Expertise in neoadjuvant therapy, laparoscopic surgery, sphincter-preserving procedures for low rectal cancer, liver metastasis management, gene-targeted therapy, and common anal conditions.
Dr. Jiang is Director of Colorectal Surgery at Shanxi Cancer Hospital, Chief Physician, Professor, and Master’s Supervisor at Shanxi Medical University. Dr. Jiang leads a provincial science and technology project and has published over 20 academic papers in SCI-indexed and national medical journals.
Professional roles
- Chair, Accelerated Recovery Surgery Committee, Shanxi Anti-Cancer Association
- Vice Chair, Colorectal Cancer Professional Committee, Shanxi Anti-Cancer Association
- Vice Chair, Shanxi Branch of Anorectal Disease, China Association of Integrative Medicine
- Member, Colorectal Cancer Liver Metastasis Treatment Professional Committee, China International Medical Promotion Association
Name order: in Chinese the family name comes first (Jiang Bo). Papers usually list the name as Bo Jiang or Jiang B.
Selected publications
15 papers on PubMed matched by name and affiliation; 3 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Nutr, 2024 (senior author): COX19 Is a New Target of MACC1 and Promotes Colorectal Cancer Progression by Regulating Copper Transport in Mitochondria. PubMed 38141772
- Biochem Genet, 2023 (senior author): Circ-IGF1R Affects the Progression of Colorectal Cancer by Activating the miR-362-5p/HMGB3-Mediated Wnt/β-Catenin Signal Pathway. PubMed 36542208
- Cancer Biol Ther, 2020 (senior author): Long non-coding RNA FALEC promotes colorectal cancer progression via regulating miR-2116-3p-targeted PIWIL1. PubMed 33073675
- World J Gastroenterol, 2014 (first author): Possible roles of insulin, IGF-1 and IGFBPs in initiation and progression of colorectal cancer. PubMed 24587638
- Zhonghua Wei Chang Wai Ke Za Zhi, 2009 (first author): [Association of insulin, insulin-like growth factor and insulin-like growth factor binding proteins with the risk of colorectal cancer]. PubMed 19434535
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion